Plain-English translation of NCT07794800 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study following 340 patients who have undergone stem cell transplant to better understand a condition called ocular chronic graft-versus-host disease—an eye complication that can develop after transplantation. Researchers will track patients over time with eye exams and ask about their symptoms to learn how common this condition is, who is most at risk, and how it affects quality of life.
Eye problems after stem cell transplant are not well understood, and doctors need better information about how often they occur and which patients are most vulnerable. This study aims to fill that knowledge gap so that patients can be better prepared and monitored.
You likely qualify if…
You likely don't qualify if…
You will visit multiple medical centers for comprehensive eye exams performed by ophthalmologists and blood specialists. During these visits, doctors will evaluate your eyes carefully and ask you about any symptoms or vision problems you are experiencing. Over time, researchers will track your eye health and gather information from your medical records to understand the long-term effects of transplant on eye health.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
China
Sponsor
Ruijin Hospital
Enrollment target
~340 participants
Started
June 2026
Primary completion
June 2030
Age range
14 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Chuanhe Jiang
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.